A detailed history of Harvest Fund Management Co., LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 11,518 shares of EW stock, worth $1.05 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
11,518
Previous 108 10564.81%
Holding current value
$1.05 Million
Previous $8,000 13650.0%
% of portfolio
0.1%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $827,681 - $1.09 Million
11,410 Added 10564.81%
11,518 $1.1 Million
Q3 2023

Nov 06, 2023

SELL
$69.28 - $93.38 $152,346 - $205,342
-2,199 Reduced 95.32%
108 $7,000
Q2 2023

Jul 07, 2023

BUY
$81.41 - $94.33 $185,533 - $214,978
2,279 Added 8139.29%
2,307 $218,000
Q1 2023

May 10, 2023

BUY
$74.26 - $84.51 $2,079 - $2,366
28 New
28 $2,000
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $123,065 - $154,906
-1,207 Reduced 72.67%
454 $53,000
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $120,623 - $148,191
-1,134 Reduced 40.57%
1,661 $216,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $209,421 - $249,796
2,035 Added 267.76%
2,795 $316,000
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $14,504 - $18,123
173 Added 29.47%
760 $79,000
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $42,082 - $53,552
587 New
587 $53,000
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $60,533 - $93,555
-1,155 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $2,724 - $3,119
-38 Reduced 3.19%
1,155 $230,000
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $33,606 - $41,184
546 Added 84.39%
1,193 $262,000
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $30,984 - $41,440
647 New
647 $124,000
Q3 2018

Oct 31, 2018

SELL
$45.7 - $58.03 $13,298 - $16,886
-291 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $10,560 - $11,299
291
291 $32,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.